Page 113 - Read Online

Muroy et al. Neuroimmunol Neuroinflammation 2020;7:166-82 I http://dx.doi.org/10.20517/2347-8659.2020.16 Page 181

6. Wake H, Moorhouse AJ, Miyamoto A, Nabekura J. Microglia: actively surveying and shaping neuronal circuit structure and function.
Trends Neurosci 2013;36:209-17.
7. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci
2007;10:1387-94.
8. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, et al. A Nurr1/CoREST pathway in microglia and astrocytes protects
dopaminergic neurons from inflammation-induced death. Cell 2009;137:47-59.
9. Mosher KI, Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem Pharmacol 2014;88:594-604.
10. Hickman S, Izzy S, Sen P, Morsett L, El Khoury J. Microglia in neurodegeneration. Nat Neurosci 2018;21:1359-69.
11. Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med 2017;23:1018-27.
12. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell
2010;140:918-34.
13. McCoy MK. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss
of dopaminergic neurons in models of Parkinson’s disease. J Neurosci 2006;26:9365-75.
14. Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, et al. Mice deficient in TNF receptors are protected against
dopaminergic neurotoxicity: implications for Parkinson’s disease. FASEB J 2002;16:1474-6.
15. Glass CK, Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 2005;6:44-55.
16. Glass CK, Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev
Immunol 2010;10:365-76.
17. Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat Rev Immunol 2009;9:692-703.
18. Smale ST, Natoli G. Transcriptional control of inflammatory responses. Cold Spring Harb Perspect Biol 2014;6:a016261.
19. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007;128:669-81.
20. Smale ST, Tarakhovsky A, Natoli G. Chromatin contributions to the regulation of innate immunity. Ann Rev Immunol 2014;32:489-511.
21. Soreq L, Rose J, Soreq E, Hardy J, Trabzuni D, et al. Major shifts in glial regional identity are a transcriptional hallmark of human
brain aging. Cell Rep 2017;18:557-70.
22. Han X, Gui B, Xiong C, Zhao L, Liang J, et al. Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural
development. Mol Cell 2014;55:482-94.
23. Baruch K, Deczkowska A, David E, Castellano JM, Miller O, et al. Aging. Aging-induced type I interferon response at the choroid
plexus negatively affects brain function. Science 2014;346:89-93.
24. Gabuzda D, Yankner BA. Physiology: inflammation links ageing to the brain. Nature 2013;497:197-8.
25. Godbout JP, Chen J, Abraham J, Richwine AF, Berg BM, et al. Exaggerated neuroinflammation and sickness behavior in aged mice
following activation of the peripheral innate immune system. FASEB J 2005;19:1329-31.
26. Sparkman NL, Johnson RW. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress.
Neuroimmunomodulation 2008;15:323-30.
27. Stewart SA. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003;9:493-501.
28. Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW. Optimized large-scale production of high titer lentivirus vector
pseudotypes. J Virol Methods 2004;122:131-9.
29. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics
2012;29:15-21.
30. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol
2014;15:31-21.
31. Blighe K, Rana S, Lewis M. emphEnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling n.d.
Available from: https://doi.org/10.18129/B9.bioc.EnhancedVolcano [Last accessed on 6 Mar 2020]
32. Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, et al. Metascape provides a biologist-oriented resource for the analysis of
systems-level datasets. Nat Commun 2019;10:1523.
33. Craik FIM, Salthouse TA. The handbook of aging and cognition. 1st ed. Psychology Press; 2011.
34. Simen AA, Bordner KA, Martin MP, Moy LA, Barry LC. Cognitive dysfunction with aging and the role of inflammation. Ther Adv
Chronic Dis 2011;2:175-95.
35. Nagamoto-Combs K, Kulas J, Combs CK. A novel cell line from spontaneously immortalized murine microglia. J Neurosci Methods
2014;233:187-98.
36. Zhao J, Bi W, Xiao S, Lan X, Cheng X, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice.
Sci Rep 2019;9:5790.
37. Glaros TG, Chang S, Gilliam EA, Maitra U, Deng H, et al. Causes and consequences of low grade endotoxemia and inflammatory
diseases. Front Biosci (Schol Ed) 2013;5:754-65.
38. Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, et al. Imaging robust microglial activation after lipopolysaccharide
administration in humans with PET. Proc Natl Acad Sci U S A 2015;112:12468-73.
39. Brown GC. The endotoxin hypothesis of neurodegeneration. J Neuroinflammation 2019;16:180.
40. Chen YC, Yip PK, Huang YL, Sun Y, Wen LL, et al. Sequence variants of toll like receptor 4 and late-onset Alzheimer’s disease. PLoS
One 2012;7:e50771.
41. Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, et al. Role of TLR4 in the gut-brain axis in Parkinson’s disease: a
translational study from men to mice. Gut 2019;68:829-43.
42. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511.
43. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004;16:3-9.
44. Chen LF, Greene WC. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 2004;5:392-401.